Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001873394-26-000005

President, Research & Develop. gave up 2,079 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan President, Research & Develop. 2026-09-02 Shares withheld for taxes −2,079 $7.14 $14,852 214,238 D: show line 1 in the form
Loading xslF345X06/wk-form4_1788470182.xml…